Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®) in Tumors of the Pancreas, Submucosal Tumors and Lymph Node Disease of the Upper GI Tract

NCT03621852 is registered in ClinicalTrials.gov with Philipps University Marburg as lead sponsor.

NCT NCT03621852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03621852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®) in Tumors of the Pancreas, Submucosal Tumors and Lymph Node Disease of the Upper GI Tract
Lead sponsor
Philipps University Marburg
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2017
Completion date
July 1, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node disease, submucosal tumor of gastrointestinal tract (disorder), tumors of the pancreas